Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hot Flashes 3Breast Neoplasms 3Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Depression 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Adenocarcinoma 1

Interventions

Radiotherapy 3Chemotherapy, Adjuvant 3Magnetic Resonance Spectroscopy 2Letrozole 2Carboplatin 2gallium 68 PSMA-11 1fluciclovine F-18 1atamestane 1Zolpidem 1Venlafaxine Hydrochloride 1Trastuzumab 1Toremifene 1Thiotepa 1Tamoxifen 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiosurgery 1Radiation 1Proton Therapy 1Paclitaxel 1Melphalan 1Mass Spectrometry 1Indocyanine Green 1Immunohistochemistry 1Histocompatibility Testing 1Gene Expression Profiling 1Fulvestrant 1Fluorescent Antibody Technique 1Estrogen Receptor Modulators 1Drugs, Generic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Lobular × Venlafaxine Hydrochloride × Clear all
NCT00084669 2010-04-28

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Massachusetts General Hospital

Phase NA Completed
119 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sleep Wake Disorders, Carcinoma, Lobular, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡